Introduction

Osteomyelitis is a progressive inflammatory process, caused by infectious agents, that can lead to bone destruction and sequestra formation. In the developed world, it occurs in adults most frequently as a result of trauma and subsequent surgery [1,2,3]. The risk of osteomyelitis varies with rates of less than 1% reported in closed injuries, and as high as 50% following open fractures [3, 4]. Infection likely occurs following direct inoculation at the time of injury or during surgery, the risk being exacerbated by damage to the local blood supply and soft tissue envelope [5]. In open fractures, increased time from injury to administration of antibiotics and debridement have both been associated with an increased risk of osteomyelitis [3, 6,7,8]. Other risk factors include diabetes mellitus, hypoxic lung disease, renal or hepatic failure, major-vessel disease, smoking, peripheral neuropathy and increasing age [9,10,11,12,13,14].

Treatment options for post-traumatic osteomyelitis (PTOM) include a non-operative, supportive approach with management of acute exacerbations, limb reconstruction surgery with the intention of eradicating infection, and amputation. Decision making is based on the patient’s wishes, the severity of their symptoms, the complexity of the pathology, and the patient’s general medical condition. Surgical treatment can be complex and usually includes debridement of all devitalised tissues, dead space management and formal soft tissue cover when required [15, 16]. Where implants are present, these will require removal in the chronic phase with simultaneous management of non-union if the fracture has not healed [17,18,19,20].

Management of chronic osteomyelitis will often be protracted, and late recurrence is not uncommon [21, 22]. Complex surgery will potentially cause further damage to an already injured limb, and the level of function achieved even following successful treatment may well be poor. Despite this, few previous studies have specifically examined outcomes in patients following the management of PTOM. Those that exist are limited by small sample sizes and short follow-up. Such information is important in counselling patients who are considering different treatment options. The aim of this study, therefore, is to investigate the long-term outcome of operatively managed tibial/femoral PTOM to determine (1) what are the long-term recurrence rates? (2) what are the long-term amputation rates? and (3) do patient reported outcome measures return to that of the normal population following successful treatment?

Patients and methods

The study plan was approved by our local institutional review board (Institutional review board number #5689). A cross-sectional retrospective series of patients presenting to our institution between September 2009 and August 2016 was conducted, with patients identified from our prospectively assembled database. Patients aged 18 years or older, with a confirmed diagnosis of PTOM of the tibia or the femur defined according to the 2017 consensus definition for fracture-related infections (FRI) were included [23]. Exclusion criteria comprised osteomyelitis without preceding trauma, osteomyelitis secondary to septic arthritis, osteomyelitis following pathological fractures and patients followed-up at other institutions. Patients undergoing non-operative management or presenting with infected non-unions were not included in this study due to the different treatment strategies, and therefore, outcomes expected in these patient groups.

Information contained in the database was supplemented by a comprehensive review of the patient’s case notes and imaging. Demographics and clinical details including age, gender, injury characteristics, overall injury severity, details of treatment strategy, organisms cultured from deep samples, and duration of orthopaedic follow-up were recorded. Overall injury severity was quantified using the Injury Severity Score [24]. Osteomyelitis was classified according to both the Cierny–Mader and the BACH classifications [25, 26].

Patients were asked to provide patient reported outcome measures (PROMS) having been invited to attend a face-to-face clinic. This included the collection of the Lower Extremity Functional Score (LEFS) [27] and the EuroQol EQ-5D-3L, and the EQ-VAS [28].

Missing data and loss to follow-up, both of which may bias results, are clearly reported. The characteristics of patient groups in these situations were compared to ensure that there were no fundamental differences in demographics or treatment strategy.

Clinical management

A management strategy was selected based upon the patient’s wishes, guided by the treating clinician. Treatment was led by a consultant orthopaedic surgeon working alongside a consultant plastic surgeon, where the quality of the soft tissue envelope was a concern.

For limb salvage, debridement of the devitalised bone and soft tissue was undertaken. The Reamer–Irrigator–Aspirator (RIA) system was used to augment debridement, where intramedullary sepsis was present. Further operative management included dead space management, delivery of local antibiotics via absorbable or polymethyl methacrylate spacers and soft tissue coverage where required. Antibiotic prophylaxis was administered after deep samples were obtained for microscopy and culture.

Where amputation was selected as treatment, the patients were reviewed and counselled pre-operatively by clinical psychology and amputation rehabilitation services. Level of amputation was determined in consultation with the rehabilitation services based upon limb function and the location of infection with the intention of clearing all infected tissue.

Antimicrobial therapy was prescribed based upon advice from consultant microbiologists. Broad spectrum antibiotics were given post-operatively until culture results were available. Where cultures were negative, empiric antibiotics were continued at the discretion of the treating clinician and microbiology consultant. A plan for 6 weeks of systemic therapy from the definitive debridement was usually made, dependent on the clinical context. Whilst a recent Cochrane review demonstrated that there was no evidence for a specific duration or route of antibiotics, most treatment regimens usually provide antibiotics for 4–6 weeks [29]. Patients were regularly followed up in the orthopaedic clinic until it was determined that their situation was stable, and the treatment appeared to have been successful. Long-term follow-up was then arranged with patients only discharged when their functional recovery had reached a plateau and they remained infection free. All patients were provided with information on how to arrange urgent review from the service if they had symptoms of recurrent infection in the future.

Statistical analysis

Statistical analysis was performed using Prism 5.0 (GraphPad Software, CA, USA). Assumptions for parametric analysis were not met; therefore, for numeric variables, the central tendency is described as a median and spread by the interquartile (IQR) and absolute range. Non-parametric methods (Mann–Whitney U, Kruskal–Wallis, and Spearman’s rank tests) were used to examine relationships between variables. Nominal variables were compared using Chi-squared and Fisher Exact tests as appropriate. Statistical significance was assumed at p < 0.05.

Results

Patient demographics, classification and treatment

Out of 119 patients that were diagnosed with chronic osteomyelitis, 72 patients met the inclusion including 59 males and 13 females (median age 47 years, IQR 24, range 18–72). PTOM affected the tibia in 46, and the femur in 26; diagnosed at a median of 14 months following injury (IQR 36, range 5–122). Nineteen patients developed infection following an open fracture.

Of the 72 patients treated, 67 patients were initially treated by limb salvage. Fifty-six patients had orthopaedic implants removed (9 had previous implant removal, 2 never had implants in situ), thus no patient had an implant left in situ following this cycle of treatment. In 30 patients, the Reamer–Irrigator–Aspirator (RIA) system was used for debridement of the medullary canal. Forty-seven patients had local antibiotic insertion [antibiotic nail (22), antibiotic beads (5), antibiotic cement (15), or a combination of these techniques (5)]. Twenty patients required a soft tissue reconstruction as part of their operative management, including ten free-flaps, four pedicled flaps, one skin graft, and five, where a combination of these techniques was utilised. Patients underwent a median of 3 procedures (IQR 2, range 1–13) and a clinic-based follow-up of 23 months (IQR 25, range 10–119).

Details of causative organisms identified on deep culture are presented in Table 1. The most commonly isolated organism was Staphylococcus affecting 28 patients (42%). All patients undergoing limb salvage received systemic antibiotics during the post-operative period. These were delivered via the IV route only (6% patients, mean duration 42 days), oral route only (38% patients, mean duration 70 days), or IV then oral routes (56% patients, mean duration IV 14 days, mean duration oral 30 days).

Table 1 Organisms isolated from PTOM cohort (n = 72)

Recurrence

Twelve (17%) patients suffered a clinical recurrence of infection during the follow-up period (ten tibia, two femur). Recurrence occurred a median of 22-month post-treatment (IQR 39.9, range 4–65). In six cases the organism isolated was the same as that identified during the index procedure, five Staphylococcus Sp. and one Streptococcus Sp. In the other six cases, the organism isolated was different to that initially identified. These included two Staphylococcus Sp.; one Pseudomonas; one Enterobacter; one Escherichia Coli; and one polymicrobial infection (Streptococcus Sp + Staphylococcus Sp + E coli). There was no difference in time to recurrence between those patients in whom the same organism was isolated, and those where the organism was different (p = 0.50). Interestingly, two of the recurrent cases (one Pseudomonas and one Staphylococcus Sp.) did not grow an organism at the index procedure.

As would be expected those patients with recurrence required more procedures (5.7 vs 2.3 procedures; p < 0.01) and more frequent admissions (3.9 vs 2.2 admissions; p < 0.01). Recurrence rates were lower, where local antibiotics (10% with vs 33% without; p = 0.01), and RIA (6% with vs 20% without; p = 0.04) were employed, whilst they were increased when soft tissue reconstruction was required (33% with vs 10% without; p = 0.01) (Table 2).

Table 2 Impact of patient demographics, initial injury characteristics and treatment modalities on recurrence

Amputation

Nine patients underwent amputation, seven trans-tibial and two trans-femoral. This included eight patients with PTOM of their tibia, and one with PTOM of the femur. In four cases an amputation was performed following failed attempts at limb salvage, including two with uncontrollable recurrent disease. The remaining five patients underwent an amputation having chosen this option following a discussion of limb salvage vs amputation, often in the context of significant ipsilateral complications of their original trauma (summarised in Table 3). Amputations were performed at a median of 47 months following diagnosis (IQR 81, range 8–174), following 5 operative procedures (IQR 2.5, range 0–7). One patient had recurrent disease within their tibial remnant which was successfully supressed with further debridement and local antibiotics. Trends were seen towards lower amputation rates when the disease affected the femur, and when the original injury was closed (Table 4).

Table 3 Reasons for amputation
Table 4 Impact of patient demographics, initial injury characteristics and treatment modalities on requirement for amputation

Patient reported outcome measures

Out of 72 patients, 18 died (25%) prior to final review. Another 10 patients were not available for review (4 moved out of area, 3 developed dementia and 3 were uncontactable). Overall, out of the remaining 44 patients, 37 patients (84%) agreed to participate and to provide PROMs. The demographics, BACH classification, microorganisms isolated, and surgical management of these patients are summarised in Tables 5, 6, and 7. When compared to the cohort of patients unavailable to provide PROMS, there were no differences in demographics, injury characteristics, or treatment strategy employed. PROMs were obtained at a median of 111 months (range 66–177 months) following diagnosis of PTOM.

Table 5 Demographics, initial injury classification and BACH classification of PROMs cohort (n = 37)
Table 6 Organisms isolated from PROMs cohort (n = 37)
Table 7 Surgical management and follow-up of PROMs cohort (n = 37)

Lower extremity functional scale

Within our cohort the median LEFS was 60 (IQR 40, range 21–80). Only two factors appeared to be associated with LEFS (Table 8): the utilisation of the RIA system (69.6 with vs 52.8 without; p = 0.02); and the overall BACH classification (74.4 for uncomplicated vs 58.4 for complex; p = 0.02). When examining the breakdown of the BACH classification, both the BACH coverage classification (66.4 for C1 vs 49.2 for C2; p = 0.01) and BACH host status (61.6 for H1 vs 42 for H2; p = 0.03) were associated with outcome.

Table 8 PROMs of patients undergoing treatment for PTOM. EQ-5D-3L presented as index score (n = 37)

EQ-5D-3L and EQ-VAS

The median EQ-5D-3L index score was 0.760 (IQR 0.484, range − 0.239 to 1.000), and the median EQ-VAS was 80 (IQR 40, range 12–100). The use of RIA was associated with significantly higher EQ-5D-3L scores (0.883 with vs 0.604 without; p = 0.04) (Table 8). This was not, however, seen with EQ-VAS (80 with vs 62.5 without; p = 0.14). Unlike LEFS, overall BACH classification did not demonstrate association with either EQ-5D-3L (0.778 for uncomplicated vs 0.725 complex), or EQ-VAS (80 for uncomplicated vs 70 for uncomplicated). We did, however, note significantly higher scores in the EQ-VAS when wider antimicrobial options were available (85 for A1 vs 60 for A2 and 60 for Ax; p = 0.04), and when soft tissue reconstruction was not required (80 for C1 vs 65 for C2; p = 0.04).

Discussion

Within PTOM, prior literature reports a significant level of morbidity including impaired ambulation, chronic pain, and an inability to re-secure employment [30, 31]. These studies frequently focus on binary outcomes which do not reflect the functional deficit that many patients continue to live with, despite no active signs of residual infection. To our knowledge this study presents one of the largest cohort of limb specific PROMS in patients with lower limb PTOM, with the longest follow-up published to date. We demonstrate the ongoing morbidity suffered by this patient group, with levels of function below that of the average population, even following “cure”.

Recurrence

Prior literature reports that 90% of recurrences occur within 2 years of treatment for post-traumatic osteomyelitis [32, 33]. It has been noted that patients presenting more than 3 years following treatment had usually sustained a new injury, undergone a further procedure, or isolated different organisms suggesting that they are re-infections as opposed to recurrence [33]. Within our cohort the rate of recurrence was 17%, with a median time to recurrence being 22 months. Only seven patients presented within 2 years (2-year recurrence rate 9.7%). None of our patients presenting after 2 years had sustained further injury or undergone further operative procedures. In six cases, the organism isolated at the revision procedure was different to that originally isolated; however, there was no difference in the time to presentation between those patients, where the recurrence organism was the same as the original, and those where it differed.

Previously recorded risk factors for recurrence include increasing age, symptoms for more than 3 months prior to treatment, pseudomonal infection, and non-operative treatment [34, 35]. Within our cohort we observed reduced recurrence rates with the use of RIA as an adjunct to debridement, and when soft tissue reconstruction was not required. RIA is used to debride and irrigate the canal in patients with medullary sepsis [35]. We observed a 6% recurrence rate in these patients compared with 20% in those receiving other treatments. This reduction may represent a selection bias towards patients with less complex bone lesions, as opposed to a treatment effect. Previous reports are consistent with low recurrence rates following treatment of medullary sepsis using this approach [36,37,38]. Similarly, we would also propose that patients requiring soft tissue reconstruction are likely to have more severe disease, potentially suggesting that disease pattern and severity are likely the most important determinants of recurrence.

Recurrence rates were also significantly lower when local antibiotic void fillers were utilised at the surgical site, a technique that is well-described. These provide very high concentrations of antibiotics whilst occupying dead space and preventing haematoma formation and suppuration. Several studies have previously reported significant improvement in outcome associated with the use of these agents compared with standard of care. Recurrence rates in case series vary from 0 to 24%.[39,40,41,42]. In our series the recurrence rate was 10%, where local antibiotics were used, we now use these agents as standard in keeping with the majority of current treatment algorithms [38].

Amputation

Studies examining amputation in PTOM report rates ranging from 1% to 7%. Within our cohort, the amputation rate was 12.5%. Amputation is frequently utilised as a surrogate for poor outcome or treatment failure; however, there is an increasing body of literature supporting early amputation under circumstances, where the outcome is likely to be poor, or the morbidity of treatment high. Multiple studies in trauma have demonstrated that early amputation results in fewer overall complications, more rapid resolution of symptoms and equivalent or superior functional outcomes to those undergoing limb reconstruction techniques [44,45,46,47]. It is important, therefore, that the concept of functional amputation, where this approach is considered as a treatment choice rather than a last resort, is developed and discussed with patients at an early stage. Within our cohort, four amputations were performed because of failure of treatment in this cycle. In five cases amputation was performed as the primary treatment for PTOM at that point. Patients who underwent amputation reported equivalent EQ-5D-3L index scores (median 0.718 with vs 0.760) and EQ-VAS scores (median 72.5 with vs 80), suggesting that in complex cases, amputation can provide a successful and equivalent outcome. EQ-5D-3L and EQ-VAS were also satisfactory in the patient who had recurrence in their tibial remnant post-amputation (0.815 and 90, respectively).

Patient reported outcome measures

The use of PROMS to record more meaningful outputs for research and monitoring of clinic care is increasing. Through improved understanding of the patient perspective, these can facilitate better communication, improved decision making, and greater patient satisfaction with care [40]. In patients with PTOM such measures may allow better recognition of the functional outcomes achieved by patients which can be used either to compare treatment strategies, or counsel patients prior to embarking with treatment.

Within our cohort the median LEFS was 60, substantially lower than those scores recorded for a healthy population (median score 77) [41]. They are similarly lower than those reported in patients suffering lower limb injury, with a LEFS of 69.4 reported at 24 weeks following ankle fractures. This suggests that outcomes in the PTOM population are substantially worse than those experienced within the standard fracture population [42]. The scores recorded by our patients were similar to those reported in two previous studies using the same measure in PTOM. The LEFS recorded in 12 patients treated for osteomyelitis of their tibia, despite a 100% infection remission rate at 50-month follow-up, was an median of 51 [31]. Similarly, another series including 35 cases of tibial or femoral osteomyelitis, with an infection remission rate of 97% at a mean of 29.5 months, reported a mean LEFS of 65.5 [43]. Neither of these studies identified demographic or operative factors associated with an improved LEFS. Within our cohort we noted that the use of RIA was associated with significantly improved outcomes, as was the classification of osteomyelitis as BACH complex.

Quality of life indicators in the form of the EQ-5D-3L index score and the EQ-VAS also demonstrated that patients failed to return to the functional baseline of the general population (0.617 vs 0.856 and 68.5 vs 82.8, respectively). Two studies have examined EQ-5D-3L and EQ-VAS in PTOM. In a series of 9 patients with polymicrobial osteomyelitis of the femur, a mean EQ-5D-3L index score of 0.360, and a mean EQ-VAS of 61.6 were reported at 21.4 months [44]. In this series all cases were classified as complex, potentially explaining the poorer outcomes achieved. Another study used the same measures to assess outcomes in 56 patients with tibial and femoral osteomyelitis, recording that both EQ-5D-3L index score and EQ-VAS improved from 0.284 and 58.2, respectively, to 0.740 and 78.9 at 1-year post-op, closely matching those scores seen within the general population [45]. When stratifying patients according to the BACH classification, significantly higher EQ-5D-3L and EQ-VAS scores were recorded in those with uncomplicated disease, simpler bone lesions, and limited or well-controlled co-morbidities [45]. The overall results reported in this study are higher than those achieved within our population; however, we do not have data to assess our cohorts’ functional level at baseline, and, therefore, cannot make comparisons with regard to the degree of improvement. In addition, the follow-up time in our patients is much longer at a median of 111 months, making any comparison difficult to interpret. The literature reporting PROMs in tibial and femoral PTOM is summarised in Table 9 and compared to the findings of the current study.

Table 9 Previous literature examining PROMs in patients with tibial/femoral PTOM, compared with the current study

Limitations

This study has limitations which should be considered when interpreting its findings. The study is retrospective in nature, with a moderate sample size, common to similar studies, reflecting the nature of this clinical condition. The case types are heterogenous in nature and different distributions and severity of disease are treated by differing methods. The severity and nature of the underlying condition more likely effects outcome, therefore, than the methods employed, which will be subject to significant selection bias. From the original cohort only 51% were available for PROMS collection, and whilst there were no differences in the considered variables between these groups, there may well be other inherent differences biasing these results. We excluded non-operatively managed PTOM as well as infected non-unions, and therefore, the conclusions drawn from this study cannot be applied to these patient cohorts.

Conclusions

With modern techniques, recurrence rates within the PTOM literature remain low. Amputation, whilst still undertaken in certain cases, is not associated with a significant reduction in quality of life, and does not necessarily represent a failure of treatment. PROMS demonstrate a quality of life that remains below that of the general population, though this appears to be improved in certain clinical situations. The data presented here on long-term outcomes should help counsel patients regarding likely functional recovery.